Healthcare REITs Get a Poor Diagnosis

Flickr/Images Money

Since their poor Q3 earnings preview, healthcare REITs have been under the weather. The sector is the one most at risk for poor performance in the coming months mainly due to increased supply in senior housing, according to investment banking firm Jefferies.

REITs in general have been having a hard time. But while all equity REITs reported YTD returns of 1.67% through the end of October, healthcare REITs reported a loss of 11.07%.

The toughest issue for healthcare REITs is that they don't have a cost of capital advantage compared to private capital buyers, Stifel's Dan Bernstein says, and that could be like overpaying for assets. 

In Q3, senior housing grew by 7.9%, and it's expected to grow by 3% of inventory in 2016, scaring investors. This is bad news for stocks such as Ventas and Welltower.

But there's hope. If healthcare REITs become flexible and shift investment strategies to assets like medical office properties, they might be able to survive—and even grow. [NREI]

Continue reading this story with a free account

Log in or register
Related Topics: Dan Bernstein , Jefferies , Ventas , Welltower
Sign up for more articles like this
Subscribe to Bisnow's National Newsletters
Related Stories

Inside The Nationwide Jockeying For Opportunity Zones 2.0

GTIS Partners Rebrands As Brightshore Capital, Launches $250M Debt Platform

Data Center Spills 5,000 Gallons Of Fuel Into New Jersey River

Hines And Rialto Close Office Credit Fund At $1.1B

Chipotle Adding Hundreds Of New Locations Worldwide

'Beyond A Routine Wobble': 10-Year Treasury Clears 5% Ahead Of Key Fed Meeting

Trump's DEI Crackdown Is Creating New Risks For Landlords That Lease To The Government

Airbnb Launches $250M Fund To Invest In Affordable Housing

Brookfield Buys Minority Stake In Hyperscale Data Center Developer AREP

Judge Dismisses Suit Alleging Alexandria Misled Investors Over Portfolio Strength

How Companies Can Eliminate Shadow AI And Gain Value From Artificial Intelligence Tools

Canadian CRE Investors Shrug Off Trade War, Spend $9B On U.S. Assets